Atovaquone and proguanil hydrochloride followed by primaquine for treatment of Plasmodium vivax malaria in Thailand (Q33893391)

29 July 2017

title

Atovaquone and proguanil hydrochloride followed by primaquine for treatment of Plasmodium vivax malaria in Thailand (English)

1 reference

29 July 2017

0 references

0 references

0 references

Plasmodium vivax malaria

1 reference

1 reference

Sornchai Looareesuwan

1

object named as

Looareesuwan S

1 reference

29 July 2017

2

Wilairatana P

1 reference

29 July 2017

Glanarongran R

3

1 reference

29 July 2017

Indravijit KA

4

1 reference

29 July 2017

Supeeranontha L

5

1 reference

29 July 2017

Chinnapha S

6

1 reference

29 July 2017

Scott TR

7

1 reference

29 July 2017

Chulay JD

8

1 reference

29 July 2017

publication date

1 November 1999

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

29 July 2017

published in

1 reference

29 July 2017

volume

93

1 reference

29 July 2017

issue

6

1 reference

29 July 2017

page(s)

637-640

1 reference

Survey of resistance to chloroquine by Plasmodium vivax in Indonesia

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

In vivo resistance to chloroquine by Plasmodium vivax and Plasmodium falciparum at Nabire, Irian Jaya, Indonesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

High dose of primaquine in primaquine resistant vivax malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Atovaquone and proguanil for the treatment of malaria in Brazil.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Treatment of Plasmodium vivax malaria--time for a change?

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Chemotherpeutic suppression and prophylaxis in Malaria. An experimental investigation undertaken by medical research teams in Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Vivax malaria resistant to chloroquine: case reports from Bombay

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Discovery of the hypnozoite and a new theory of malarial relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Randomised placebo-controlled study of atovaquone plus proguanil for malaria prophylaxis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

High rate of Plasmodium vivax relapse following treatment of falciparum malaria in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Treatment of primaquine-resistant Plasmodium vivax malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Vivax malaria resistant to treatment and prophylaxis with chloroquine

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Failure of combined chloroquine and high-dose primaquine therapy for Plasmodium vivax malaria acquired in Guyana, South America

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Atovaquone plus proguanil is an effective treatment for Plasmodium ovale and P. malariae malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Atovaquone and proguanil for Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Efficacy and pharmacokinetics of atovaquone and proguanil in children with multidrug-resistant Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Chloroquine-resistant Plasmodium vivax in Papua New Guinea

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Chloroquine-resistant Plasmodium vivax from Indonesia

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Efficacy and safety of atovaquone/proguanil as suppressive prophylaxis for Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Plasmodium vivax infections in U.S. Army troops: failure of primaquine to prevent relapse in studies from Somalia.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Clinical response and susceptibility in vitro of Plasmodium vivax to the standard regimen of chloroquine in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Development of resistance to chloroquine by Plasmodium vivax in Myanmar

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Why are primaquine and other 8-aminoquinolines particularly effective against the mature gametocytes and the hypnozoites of malaria?

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Drug resistant Plasmodium vivax malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

The treatment of malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Primaquine resistance in Plasmodium vivax

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

A clinical trial of mefloquine in the treatment of Plasmodium vivax malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Efficacy and safety of atovaquone/proguanil compared with mefloquine for treatment of acute Plasmodium falciparum malaria in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

10.1016/S0035-9203(99)90079-2

Identifiers

DOI

1 reference

29 July 2017

1 reference